Addus HomeCare Corporation $ADUS Stock: Sterling Capital Management LLC Reduces Holdings

Sterling Capital Management LLC lowered its stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 97.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 366 shares of the company’s stock after selling 14,107 shares during the quarter. Sterling Capital Management LLC’s holdings in Addus HomeCare were worth $40,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. Hsbc Holdings PLC grew its stake in Addus HomeCare by 73.3% during the 2nd quarter. Hsbc Holdings PLC now owns 24,463 shares of the company’s stock worth $2,446,000 after purchasing an additional 10,350 shares in the last quarter. Summit Creek Advisors LLC purchased a new stake in Addus HomeCare during the 2nd quarter worth about $8,552,000. Globeflex Capital L P purchased a new stake in Addus HomeCare during the 2nd quarter worth about $1,635,000. Bank of America Corp DE increased its holdings in Addus HomeCare by 11.3% during the 1st quarter. Bank of America Corp DE now owns 323,037 shares of the company’s stock worth $30,252,000 after purchasing an additional 32,714 shares during the period. Finally, The Manufacturers Life Insurance Company purchased a new stake in Addus HomeCare during the 2nd quarter worth about $901,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.

More Addus HomeCare News

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: TD Cowen raised its price target to $145 from $131 and kept a Buy rating, implying about 14% upside from $126.81. TD Cowen recommendations
• Positive Sentiment: Third-quarter EPS of $1.83 beat the $1.79 consensus and increased from $1.56 a year earlier. Revenue rose 7% to $387.7 million, slightly below estimates; the earnings growth and stronger adjusted EBITDA provide supportive operating context. Q3 results
• Positive Sentiment: Management expects the roughly $275 million AccentCare personal-care acquisition to close in Q1 2027 and projected a full-year adjusted EBITDA margin in the 13% range, offering a potential growth opportunity alongside its margin outlook. AccentCare timing and margin outlook
• Neutral Sentiment: Renewed discussion of Medicare for All could put home- and community-based care in focus, given Addus’ reliance on Medicaid-funded personal care. However, the policy is uncertain, and any reimbursement benefit would depend on legislation and payment rules. Healthcare stocks and Medicare for All
• Neutral Sentiment: A report says caregiver preferences for 40-hour workweeks are shaping Addus’ personal-care census strategy; the available details do not quantify the impact on staffing or growth. Caregiver scheduling strategy
• Negative Sentiment: Barclays raised its target to $101 from $96 but kept an Underweight rating, implying roughly 20% downside from $126.81—a notable counterpoint to TD Cowen’s bullish call. Barclays recommendations

Analyst Ratings Changes

ADUS has been the topic of a number of analyst reports. Truist Financial increased their price target on Addus HomeCare from $135.00 to $148.00 and gave the company a “buy” rating in a research report on Thursday. Raymond James Financial set a $137.00 price objective on Addus HomeCare in a research report on Monday, September 28th. Bank of America lowered shares of Addus HomeCare from a “buy” rating to a “neutral” rating and cut their target price for the stock from $140.00 to $125.00 in a research note on Monday, September 14th. Weiss Ratings raised shares of Addus HomeCare from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, September 24th. Finally, Royal Bank Of Canada raised their target price on shares of Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. Seven investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $134.70.

Addus HomeCare Price Performance

Addus HomeCare stock opened at $126.81 on Friday. The stock has a market cap of $2.37 billion, a P/E ratio of 21.14, a price-to-earnings-growth ratio of 1.82 and a beta of 0.75. The company has a fifty day simple moving average of $117.48 and a 200-day simple moving average of $106.80. Addus HomeCare Corporation has a 12-month low of $87.95 and a 12-month high of $131.59. The company has a current ratio of 1.64, a quick ratio of 1.69 and a debt-to-equity ratio of 0.02.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Tuesday, November 3rd. The company reported $1.83 EPS for the quarter, topping analysts’ consensus estimates of $1.79 by $0.04. The firm had revenue of $387.74 million during the quarter, compared to the consensus estimate of $388.72 million. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.22%. The company’s revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.56 earnings per share. Equities analysts expect that Addus HomeCare Corporation will post 6.33 EPS for the current fiscal year.

Addus HomeCare Company Profile

Addus HomeCare Inc (NASDAQ: ADUS) provides in-home personal care, hospice and home health services to older adults, people with disabilities and other individuals who need assistance with daily living or medical care. Its services are designed to help clients remain safely and independently in their homes while supporting families and caregivers.

The company’s personal care services include assistance with bathing, dressing, grooming, meal preparation, housekeeping and other activities of daily living.